Adults should be vaccinated against cancer-causing human papillomavirus (HPV) to save ‘thousands’ more lives, said a UK expert.
According to a dailymail.com article on September 28, 2019, cancer scientists say ‘evidence is now emerging that giving the jab to those who already harbor HPV could protect them as well,’ per Margaret Stanley of Cambridge University, president of the International Papilloma Virus Society. Read more here....
OPINION: Statements about priorities for the new cancer agency made by agency head Professor Diana Sarfati are cause for serious concern.
Last Saturday's profile of Sarfati, in which she was asked to name her three priorities, said: "One thing not on that priority wish list is more money for the stream of high-cost, life-prolonging drugs for terminal cancer, which prompt patient petitions and marches to Parliament."
So it seems prolonging
Auckland Hospital staff have apologised to a Dargaville builder left with brain damage after he was given an overdose of morphine.
Memb
Each week we share Head and Neck Cancer News from around the world....
Researchers have successfully solved a longstanding problem in the diagnosis of head and neck cancers. The researchers used artificial intelligence to develop a new classification method which identifies the primary origins of cancerous tissue based on chemical DNA changes. The potential for introduction into routine medical practice is currently b
Paul Ryder considers himself lucky to be alive.
The 68-year-old Timaru man was diagnosed with cancer in his vocal cords in 2017, but with treatment the disease went into remission and finally subsided.
He says the New Zealand Cancer Action Plan 2019–2029, announced by the Government on Sunday, should only be a start in the fight against the disease as much more than the allotted extra $60 million was needed to find a cure, and more radiation
Head and Neck Cancer Network Launches Petition
The Head and Neck Cancer Network have added their voice to the other cancer organisation calling for Pharmac to fund cancer drug Keytruda. MedSafe approved the drug for use in head and neck cancer after chemotherapy. However, Network Chair Diana Ayling says, Keytruda needs to be available as an option with surgery, radiotherapy and chemotherapy”.
At present HNC patient, Diana Craig is funding her own treatment with donations from a Give a Little Pag
This article is part of a Because It Matters Newshub series.
Described as New Zealand's "most prolific cancer survivor", Phil Kerslake says he's worried the country's falling behind in terms of cancer care, and is urging the Prime Minister and the Health Minister to pick up the pace.
Kerslake, who's survived eight new diagnoses or recurrences of cancer since 1974, says while he thinks New Zealand's "come a long way",
The Government has unveiled the first tranche of its cancer plan, announcing a $25 million spend on 12 new radiation machines nationwide.
But the plan, announced by Prime Minist
Kia ora tatou,
Network News
World Head and Neck Cancer Day 2019
We had good media coverage for the day. I would like to thank the Australia New Zealand Head and Neck Cancer Society, the New Zealand Dental Association, the Gillies MacIndoe Research Institute, the Sexually Transmitted Diseases Education Foundation, the Cancer Society, www.hpv.org.nz and the wonderful team at Wellington Zoo. A great effort. You can read all the information shared here. http://headandneck.org.nz/news/weekly-wednesd
From Radio New Zealand...."World Head and Neck Cancer Day is tomorrow and this year there's a push to highlight the correlation between these cancers and the HPV virus.
These cancers are increasing at a faster rate than other cancers, so what is the connection and is it preventable?
Jesse Mulligan was joined by Professor Swee Tan, an expert in the field, to tell us more." Click here to listen.
Most Kiwi cancer patients are keen to take part in clinical trials, a survey shows, despite a tiny proportion actually being
Pharmac has spent tens of millions of dollars funding a painkiller at the centre of the American opioid crisis. Experts say it has created a whole new population of drug users. National Correspondent Tony Wall investigates.
Oxycodone, known
Kia ora tatou,
Network News
This month we launch our fundraising campaign for the year. Although we run a lean and mean operation, we need your donations to ensure we can continue our work of connecting, supporting and advocating for people affected by head and neck cancer.
This year we are joining with Beyond Five in Australia to raise funds through Soup for the Soul. Simply, you make up a soothing, comforting bowl of soup, share it with your friends, family and colleagues. Ask your diners to
A Northland man has been left with brain damage due to a suspected morphine overdose he received in hospital.
Trevor Flood, 56, has been left confused and cannot remember how to use a TV remote, his wife Kylie Flood told Radio NZ's Morning Report.
The Kaipara builder had gone into Auckland City Hospital on February 12 dehydrated and in severe pain after a course of radiation therapy for throat cancer.
National Volunteer Week 2019
#NVW2019 https://nationalvolunteerweek.nz/
National Volunteer Week celebrates the collective contribution of the 1.2 million volunteers who enrich Aotearoa New Zealand.
National Volunteer Week 2019 runs from June 16-22. This year’s theme is “Whiri Te tangata - weaving the people together". Volunteering, Mahi Aroha and social action weave people together.
This week the Network celebrates our volunteers, and acknowledge their work. We invite more people to join us to
Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses the treatment era before immunotherapy in head and neck cancer.
Before PD-1/PD-L1 inhibitors came into the mix, there were very limited options i
Kia ora tatou,
The latest newsletter includes a full update on the Northern Regional Project to improve head and neck cancer services in the region.
You can read it all by clicking the link below.
This week our news from around the world includes Sterling K. Brown interviewing cancer survivors, a reminder about HPV and an interview acknowledging the long-term and late effects of treatment.
Sterling K. Brown is embarking on a passion project. And, much like his NBC hit This Is Us, it shines light on difficult topics.
The two-time Emmy-winning actor partnered with Bristol-Myers Squibb for a serie
